FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200091273> ?p ?o ?g. }

• W4200091273 abstract "Background: Tubulointerstitial involvement has been reported to have a decisive influence on the progression of IgA nephropathy (IgAN). High levels of urine β2-microglobulin (β2-MG) and retinol-binding protein (RBP) were observed in patients with IgAN with tubulointerstitial lesions. However, their roles in disease progression remain unclear. This study aimed to evaluate the associations of urine β2-MG and RBP with the progression of IgAN. Methods: We retrospectively investigated a cohort of 2,153 patients with IgAN. Clinical and pathological features, outcomes, and urine β2-MG, and RBP at the time of biopsy were collected. The associations, of urine β2-MG and RBP with the composite renal outcome, defined as a decline in estimated glomerular filtration rate (eGFR) of ≥50% from baseline or end-stage renal disease (ESRD), were examined using restricted cubic splines and the Cox proportional hazards models. Results: During a median follow-up of 20.40 months, 140 (6.50%) patients reached the composite renal outcomes. Restricted cubic splines showed that patients with higher urinary β2-MG and RBP levels had worse renal outcomes. The Cox regression analysis revealed that urine β2-MG and RBP were associated with a risk of the composite renal outcome in the multivariate adjusted model [+1 SD for log β2-MG, hazard ratio (HR) = 1.462, 95% CI: 1.136-1.882, p = 0.003; +1 SD for log RBP, HR = 1.972, 95% CI: 1.486-2.617, p = 0.001]. The associations were detectable within patients with baseline eGFR <90 ml/min/1.73 m2 (+1 SD for log β2-MG, HR = 1.657, 95% CI: 1.260-2.180, p < 0.001; +1 SD for log RBP, HR = 1.618, 95% CI: 1.199-2.183, p = 0.002), but not among patients with eGFR ≥90 ml/min/1.73 m2. Conclusion: Higher levels of urine β2-MG and RBP were independent risk factors for renal disease progression in IgAN." @default.
• W4200091273 created "2021-12-31" @default.
• W4200091273 creator A5011122618 @default.
• W4200091273 creator A5032454574 @default.
• W4200091273 creator A5035221448 @default.
• W4200091273 creator A5046899314 @default.
• W4200091273 creator A5070458251 @default.
• W4200091273 creator A5079602917 @default.
• W4200091273 date "2021-12-22" @default.
• W4200091273 modified "2023-09-25" @default.
• W4200091273 title "Urine β2-Microglobulin and Retinol-Binding Protein and Renal Disease Progression in IgA Nephropathy" @default.
• W4200091273 cites W1498470436 @default.
• W4200091273 cites W1542642660 @default.
• W4200091273 cites W1619203820 @default.
• W4200091273 cites W1971086200 @default.
• W4200091273 cites W1971405676 @default.
• W4200091273 cites W1983132018 @default.
• W4200091273 cites W1998134251 @default.
• W4200091273 cites W2017771333 @default.
• W4200091273 cites W2033996898 @default.
• W4200091273 cites W2036550192 @default.
• W4200091273 cites W2040141270 @default.
• W4200091273 cites W2041677815 @default.
• W4200091273 cites W2046649453 @default.
• W4200091273 cites W2056993607 @default.
• W4200091273 cites W2060607867 @default.
• W4200091273 cites W2068456857 @default.
• W4200091273 cites W2068622105 @default.
• W4200091273 cites W2068924948 @default.
• W4200091273 cites W2071111569 @default.
• W4200091273 cites W2084919451 @default.
• W4200091273 cites W2101802002 @default.
• W4200091273 cites W2128331580 @default.
• W4200091273 cites W2138761680 @default.
• W4200091273 cites W2152853007 @default.
• W4200091273 cites W2153479159 @default.
• W4200091273 cites W2155965977 @default.
• W4200091273 cites W2160421164 @default.
• W4200091273 cites W2163106904 @default.
• W4200091273 cites W2223268479 @default.
• W4200091273 cites W2331840080 @default.
• W4200091273 cites W2473804666 @default.
• W4200091273 cites W2602196428 @default.
• W4200091273 cites W2626362048 @default.
• W4200091273 cites W2889262735 @default.
• W4200091273 cites W3043143884 @default.
• W4200091273 cites W4241655994 @default.
• W4200091273 doi "https://doi.org/10.3389/fmed.2021.792782" @default.
• W4200091273 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35004762" @default.
• W4200091273 hasPublicationYear "2021" @default.
• W4200091273 type Work @default.
• W4200091273 citedByCount "1" @default.
• W4200091273 countsByYear W42000912732022 @default.
• W4200091273 crossrefType "journal-article" @default.
• W4200091273 hasAuthorship W4200091273A5011122618 @default.
• W4200091273 hasAuthorship W4200091273A5032454574 @default.
• W4200091273 hasAuthorship W4200091273A5035221448 @default.
• W4200091273 hasAuthorship W4200091273A5046899314 @default.
• W4200091273 hasAuthorship W4200091273A5070458251 @default.
• W4200091273 hasAuthorship W4200091273A5079602917 @default.
• W4200091273 hasBestOaLocation W42000912731 @default.
• W4200091273 hasConcept C126322002 @default.
• W4200091273 hasConcept C126894567 @default.
• W4200091273 hasConcept C134018914 @default.
• W4200091273 hasConcept C159641895 @default.
• W4200091273 hasConcept C207103383 @default.
• W4200091273 hasConcept C2776174234 @default.
• W4200091273 hasConcept C2776940978 @default.
• W4200091273 hasConcept C2778653478 @default.
• W4200091273 hasConcept C2779561371 @default.
• W4200091273 hasConcept C2779573558 @default.
• W4200091273 hasConcept C2780026642 @default.
• W4200091273 hasConcept C2780091579 @default.
• W4200091273 hasConcept C2781087799 @default.
• W4200091273 hasConcept C2781184683 @default.
• W4200091273 hasConcept C44249647 @default.
• W4200091273 hasConcept C50382708 @default.
• W4200091273 hasConcept C555293320 @default.
• W4200091273 hasConcept C71924100 @default.
• W4200091273 hasConcept C90924648 @default.
• W4200091273 hasConcept C97749175 @default.
• W4200091273 hasConceptScore W4200091273C126322002 @default.
• W4200091273 hasConceptScore W4200091273C126894567 @default.
• W4200091273 hasConceptScore W4200091273C134018914 @default.
• W4200091273 hasConceptScore W4200091273C159641895 @default.
• W4200091273 hasConceptScore W4200091273C207103383 @default.
• W4200091273 hasConceptScore W4200091273C2776174234 @default.
• W4200091273 hasConceptScore W4200091273C2776940978 @default.
• W4200091273 hasConceptScore W4200091273C2778653478 @default.
• W4200091273 hasConceptScore W4200091273C2779561371 @default.
• W4200091273 hasConceptScore W4200091273C2779573558 @default.
• W4200091273 hasConceptScore W4200091273C2780026642 @default.
• W4200091273 hasConceptScore W4200091273C2780091579 @default.
• W4200091273 hasConceptScore W4200091273C2781087799 @default.
• W4200091273 hasConceptScore W4200091273C2781184683 @default.
• W4200091273 hasConceptScore W4200091273C44249647 @default.
• W4200091273 hasConceptScore W4200091273C50382708 @default.
• W4200091273 hasConceptScore W4200091273C555293320 @default.
• W4200091273 hasConceptScore W4200091273C71924100 @default.
• W4200091273 hasConceptScore W4200091273C90924648 @default.

• next